Key facts
- It has raised $590K; the latest was Seed Round ($590K) in Sep 2025.
- Notable investors include LRM, Seeder Fund.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Monsana
- ·The full record, as it builds
Funding rounds
No funding rounds for Monsana are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Monsana
Developer of an AI-based clinical trial matching platform designed to help doctors identify suitable treatment options for patients. The company's platform screens patient records in any format, scores eligibility, notifies doctors of matches, reduces manual workload, and speeds recruitment, enabling healthcare providers and life science companies to improve patient access and streamline clinical research.
- Sector
- Healthcare
- HQ
- Hasselt, Belgium
- Founded
- 2024
- Employees
- 3
- Website
- monsana.ai/
- Ownership
- Privately Held (backing)
Monsana doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Monsana shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Monsana in its N-PORT filings yet. We sweep new filings monthly.